<DOC>
	<DOCNO>NCT03082352</DOCNO>
	<brief_summary>The purpose study compare bioavailability generic product metoprolol reference product administer healthy volunteer fast condition . The test product BF-Metoprolol Tablets 100mg manufacture Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited reference product Betaloc Tablet 100mg . The plasma kinetic data metoprolol obtain two formulation use access interchangeability product .</brief_summary>
	<brief_title>Clinical Bioequivalence Study Two Metoprolol Tablet 100mg Formulations</brief_title>
	<detailed_description>The study design single-dose , two-treatment , two-period , two-sequence cross washout period one two week . Subject randomly assign two group correspond two dose sequence . Each subject undergo two study ( treatment ) session , single oral dose 100mg metoprolol either test reference formulation administer . The estimated duration subject 's participation 29-36 day ( i.e . 3 week screen medication restraint , 1 day study ( treatment ) session I II , 1 - 2 week washout period . Venous blood sample collect pre-dose ( 0h ) , 24h post dose . The plasma concentration metoprolol determine validated assay . The non-compartmental method use analyze plasma concentration-time data calculate main pharmacokinetic parameter Cmax , Tmax , AUC0-last , AUC0-inf , T1/2 . ANOVA calculate logarithmically transform Cmax , AUC0-last AUC0-inf . The two one side test use calculate 90 % confidence interval mean difference AUC0-last , AUC0-inf Cmax assess bioequivalence two product</detailed_description>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Male nonpregnant female , 18 55 year age Body Mass Index 18 30 kg/m2 Accessible vein blood sample High probability compliance completion study Female subject must agree practice abstinence take effective contraceptive method prevent pregnancy start screen two week last dose administration Clinically significant hepatic , renal , biliary , cardiovascular , gastrointestinal , haematological chronic acute disease within 3 month prior study Clinically significant abnormality physical examination , vital sign , laboratory test result , ECG evaluation , urine test , blood chemistry haematological test Regular consumption tobacco use form Regular consumer alcohol ( one drink per day ) Blood donation within 4 week prior start study Use metoprolol within 4 week study Use antihypertensive medication beta blocker within 4 week study Volunteer clinical drug study within 2 month prior study Hypersensitivity metoprolol drug class History drug abuse form Female subject breastfeed pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>